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Abstract
Aim of the research: to establish the role of undifferentiated connective tissue dysplasia, as a manifestation of violation of 
fibrillogenesis, in the severity of the course of pyelonephritis in children.
148 children with pyelonephritis from 3 to 18 years were examined. As a result of catamnestic surveillance, they were divided 
into 2 groups: I – 92 persons, children with chronic pyelonephritis in which were diagnosed 3 or more episodes of relapse of pyelone-
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phritis during the year, and II – 56 children with acute pyelonephritis, in which during the year no relapses were noted. The control 
group were 65 somatically healthy children of the same age (III – health-control). All children had a routine comprehensive clinical 
and laboratory examination and clinical and laboratory markers of a fibrillogenic disorder were established. 
In children with chronic pyelonephritis, the frequency of all analyzed complaints was significantly higher than in children 
with acute pyelonephritis without relapses: frequent headaches – 56.52 % versus 25.0 %, appetite loss – 28.26 % vs. 19.64 %, frequent 
abdominal pain – 52.17 % vr. 32.14 %, increased fatigue – 41.30 % vr. 28.57 %.
In children with chronic pyelonephritis, phenotypic signs of undifferentiated connective tissue dysplasia (UCTD) were sig-
nificantly more marked, such as joint hypermobility (in 52.0 % of children versus 5.4 %), asthenic body structure (59.0 % vs. 
26.78 %), visual disturbance (84.8 % vs. 32.14 %), chest deformity (42.4 % vs. 8.9 %), scoliosis (52.17 % vs 10.7 %), arachnodactyly 
and predisposition to bleeding were observed only in children of the 1st group (22.5 % and 4.34 % respectively).
In practically all children with chronic pyelonephritis, the values of free and bound oxyproline fractions in blood plasma were 
significantly increased (47.14±0.03 μmol/l and 40.08±0.03 μmol/l, respectively), according to arithmetic meanings, reliably differing 
from the data of children with acute pyelonephritis (17.65±0.01 μmol/l and 17.22±0.02 μmol/l), in which these oxyproline fractions 
were elevated only in 12.0 % and 16.0 % of the subjects.
In 97.0 % of children with chronic pyelonephritis, the level of oxyproline in urine was elevated and significantly exceeded the 
level of excretion of oxyproline in urine in children with acute pyelonephritis. 
The presence of UCTD in a child plays an important role in the process of chronic pyelonephritis, and children with its 
manifestations have a heavier course of disease with frequent relapses, therefore, the presence of signs UCTD is prognostically un-
successful, which dictates the need for the appointment of metabolic therapy in the first episodes of the disease in children, if they 
have clinical and laboratory manifestations of UCTD.
Keywords: children, dysplasia of connective tissue, violations of fibrillogenesis, clinical and laboratory markers, oxyproline, 
pyelonephritis, kidneys.
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1. Introduction
Diseases of the organs of the urinary system take one of the leading places in the structure 
of childhood diseases. According to statistics, their prevalence has increased over the years. The 
frequency of their low-symptomatic atypical prograding is increasing [1].
In recent years, not only in Ukraine, but also in the world, attention is focused on the in-
crease in the frequency of diseases of the organs of the urinary system. At the same time, the struc-
ture of nephropathy in children is dominated by diseases of the congenital and hereditary genesis, 
as well as diseases associated with hereditary predisposition, with a latent onset and torpid flow [2]. 
Particular attention deserves children with manifestations of connective tissue dysplasia (CTD) [3].
Data from studies conducted in the European post-soviet area show the prevalence of undif-
ferentiated connective tissue dysplasia (UCTD) from 9.0 % to 80.0 %, depending on the age, sex, 
ethnic and clinical groups of the study. At the same time, scientists are concerned about the pro-
gressive growth in the population of individuals with a displastic phenotype, which is considered as 
the result of the impact of new mutagenic factors of social, technological and environmental nature, 
which form an increase in the so-called “genetic cargo” [4, 5]. The idea of “syndrome violation of 
gene homeostasis” were formulated, which may be the result of a mutation of one (monogenic the-
ory), and several (polygenic theory) of genes [6, 7]. The uniqueness of the structure and functions 
of the connective tissue creates conditions for the emergence of a large number of its anomalies and 
diseases caused by chromosomal and gene defects that have a certain type of inheritance or arise 
as a result of external mutagenic effects in the fetal period [8]. In addition to a large number of dis-
eases, most often based on gene defects, birth defects of the connective tissue (CT) of multifactorial 
nature are often present today [9, 10].
CTD are linked both to a violation of the synthesis of collagen and fibrilogenesis, as well 
as with changes in its biodegradation, fermentopathies, defects of fibronectin, elastin, glycopro-
teins, proteoglycans, and also with a deficiency of various cofactors of enzymes (magnesium, zinc, 
copper), ascorbic acid, oxygen and etc., which are involved in the formation of covalent bonds 
necessary to stabilize collagen structures, which are based on the mutations of genes encoding the 
synthesis and spatial organization of CT elements [6, 11].
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In practice, it is more often encountered with undifferentiated forms of CTD - a geneti-
cally heterogeneous group of diseases of multifactorial nature with progressive flow, which are 
based on the violation of the synthesis, degradation or morphogenesis of the components of the 
extracellular matrix that occurs during the period of early embryogenesis or postnatal one under 
the influence of unfavorable environmental factors and can be manifested in different periods of 
life [12, 13].
Kidneys take part in any pathological processes, since they are one of the main organs that 
support the homeostasis of the body at any age. Clinical manifestations of many diseases in chil-
dren to a large extent depend on the degree of maturity of urinary organs and urination [14, 15].
Taking into account the above remains an open question about the role of dysplasia of con-
nective tissue (DCT) in pyelonephritis in children, the signs of which are increasingly encountered 
among patients nephrology and significantly affect the nature and course of the disease that causes 
the occurrence, chronicity and its resistance to therapy.
2. Aim of the research
To establish the role of undifferentiated connective tissue dysplasia, as a manifestation of 
violations of fibrilogenesis, in the severity of the course of pyelonephritis in children.
3. Materials and methods
148 children aged 3 to 18 years old underwent inpatient treatment with a diagnosis of pyelo-
nephritis in the I pediatric department of the KZ LOR LODCL “OKHMATDYT” in 2016–2017. 
According to the results of the observation of patients in the catamnesis of the 1st and 3rd years, 
they were divided into 2 groups according to the severity of the disease and the frequency of ep-
isodes of exacerbation of the inflammatory process of the kidneys: group I (І-CP – 92 persons) – 
children with chronic pyelonephritis, in which there was a more severe course of the disease both 
in the debut and in the catamnesis, they were diagnosed with 3 or more episodes of pyelonephritis 
relapse throughout the year, the second group (II-AP – 56 children) who had been diagnosed with 
acute pyelonephritis, was noticed a mild course of pyelonephritis in the debut of the disease during 
the year of catamnestic observation no relapse of the disease was noted.
The results of the study of the children of the main groups were compared with the results of 
a survey of healthy children – 65 somatically healthy children of the same age (ІІІ-health-control), 
which were surveyed during the trips of a group of researchers in ecologically clean areas of Lviv 
region within the framework of the planned research work. All children were given a comprehen-
sive clinical and laboratory examination in accordance with standard, commonly used in pediatric 
nephrology and pediatrics by clinical, laboratory and instrumental examinations [16].
When the children received next steps were done:
– a thorough survey of children and their parents by a specially designed questionnaire to 
specify the necessary anamnestic data;
– clinical examination of children and anthropometric measurements to determine the phe-
notypic signs of undifferentiated connective tissue dysplasia;
– routine clinical, laboratory parameters (general blood test, general urine analysis, bio-
chemical analysis of blood) and instrumental methods of examination (renal ultrasound, cystic 
cystography, excretory urography) were determined;
– Brighton and modified criteria of Milkovskaya-Dimitrova and Karkasheva [17] deter-
mined the phenotypic signs of undifferentiated connective tissue dysplasia.
– levels of excretion of oxyproline in urine were determined based on the method by 
E. O. Yuryeva, V. V. Ilgov in modification O. O. Dobryk, S. L. Nyankovsky, M. Yu. Iskiv [1, 18] and 
free and bound fraction of oxyproline in blood serum using N. P. Sharaeva method [19].
The statistical processing of the research results was carried out using the Microsoft Excel 
program and the application package Statistica 5.0 for Windows. For the processing of the results 
that fell under the normal distribution, used the statistical method with the deduction of the arith-
metic mean (M), standard deviation (SD). Calculations of the main statistical quantities were car-
ried out according to generally accepted formulas [20].
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4. Results of the research
In children of all observed groups, clinical and paraclinical manifestations of undifferentiat-
ed connective tissue dysplasia and violations of fibrillogenesis were investigated.
In children of the I group, complaints of frequent abdominal pain were noted in 52.17 % of 
cases, while in children of the II group only 32.14 % of the subjects (in control – 7.5 %). Complaints 
on frequent headaches were noted in 56.52 % of children in group І, whereas in children of the 
group ІІ only 25.0 % of children (in control – 4.2 %). The complaints about fast fatigability were 
noted in 41.3 % of children in group І, whereas in children of group ІІ fatigue was noted only in 
28.57 % of children (in control – 5.6 %). Dysuricular manifestations in children of the I group were 
noted in 63.04 % of children, while in ІІ group - only in 55.35 % of children (in control – 2.04 %). 
In addition, complaints of frequent nosebleeds were noted in 4.34 % of children in group І, which 
was not observed in children of the ІІ group (in control – 0.02 %).
In patients of all the observation groups, a history of life was collected, with an emphasis on 
the study of the frequency of antenatal and postnatal risk factors for the formation of the urinary 
system pathology and violations of fibrillogenesis (Table 1).
Table 1
The frequency of ante- and postnatal non-specific risk factors for the formation of pathology
Non-specific risk factors:
Groups of children:
І-CP, n=92 ІІ-AP, n=56 ІІІ-health-control, n=65
n % n % n %
The threat of miscarriage 17 18.48* 9 16.07* 6 0.09
Gestosis of the first half of pregnancy 58 63.04*.** 16 28.57* 10 0.15
Gestosis of the second half of pregnancy 26 28.26* 12 21.43* 5 0.08
Mother’s anemia during pregnancy 57 61.96*.** 12 21.43* 5 0.08
Early artificial feeding 48 52.17*.** 13 23.21* 9 0.14
Frequent ARD 56 60.87*.** 17 30.36* 8 0.12
Atopic diathesis in the past 8 8.7*.** 5 8.93* 1 0.02
Note:* – the probable difference between the data of children with pyelonephritis and healthy control group р <0.01; ** – the prob-
able difference in the indicator between two groups of children with pyelonephritis; p <0.01
After children with pyelonephritis came, clinical manifestations and results of ultrasound 
examination of patients’ kidneys were analyzed (Table 2).
Clinical manifestations of general non-specific intoxication were registered in most chil-
dren of the І group: pallor of the skin was noted in 1.5–2 times more often than in children of the 
ІІ group (52.0 % vs. 32.0 % of the children in the comparison group), periorbital cyanosis was noted 
2 times more frequently in patients of the І group (43.0 % vs. 23.0 % of the children in the compar-
ison group); signs of dysmetabolic nephropathy according to ultrasound data were also diagnosed 
2.5 times more often in children of the main group (57.0 % against 20.0 % of children in the com-
parison group), ultrasound signs of inflammatory process of the kidneys met in 93.0 % of children 
of both group. Reliable difference in performance of muffled tones of the heart, dental enamel 
hypoplasia in children of observation group was not noted (Table 2).
In order to study the possible role of undifferentiated connective tissue dysplasia as the 
causes of the more severe course of pyelonephritis in children and the propensity to chronize the 
process, as well as in order to predict frequent relapses of pyelonephritis in children, the nature 
and frequency of phenotypic manifestations of undifferentiated connective tissue dysplasia were 
analyzed (Table 3).
Table 2
Status of children with pyelonephritis according to clinical and ultrasound examination
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Clinical manifestations:
Groups of children:
І-CP, n=92 ІІ-AP, n=56
n q n q
Pale skin 48 0.52* 18 0.32
Periorbital cyanosis 39 0.43* 13 0.23
Hypertrophy of the tonsils 37 0.40 19 0.34
Micropolyadenitis 13 0.14 9 0.16
Hypoplastics of enamel of teeth, I degree 19 0.21 12 0.21
Hypoplasia of enamel of teeth, II-III degree 17 0.18 10 0.18
The presence of tooth decay 31 0.34 14 0.15
The muffled tones of the heart 14 0.15 8 0.14
Nausea and pain during epigastric palpation 24 0.26* 6 0.11
Pain during palpation of the abdomen 54 0.58* 23 0.41
Ultrasound signs of dysmetabolic nephropathy 49 0.53* 24 0.43
Ultrasound signs of inflammation of the kidneys 86 0.93 52 0.93
Note: * – the probable difference between the data of two groups of children р<0.01
Table 3
The nature and frequency of phenotypic manifestations of the examined children
Detected phenotypic manifestations of 
UCTD:
Groups of children:
І-CP, n=92 ІІ-AP, n=56 ІІІ-health-control, n=65
n % n % n %
Hypermobility of the joints 48 52.0** 3 5.4 2 3.07
Asthenic constitution 54 59.0** 15 26.78 8 12.3
Vision disorders 78 84.8** 18 32.14 5 7.69
Arachnodactyly 21 22.8** – – – –
Deformation of the chest 39 42.4** 5 8.9 3 4.62
Flatfoot 24 26.09** – – – –
Scoliostic posture 48 52.17** 6 10.7 3 4.62
Tendency to bleeding 4 4.34** – – – –
Emotional lability 38 41.3** 14 25.0 9 13.85
Umbilical hernia 9 9.78** 3 3.3 – –
Note:* – the probable difference between the data of children with pyelonephritis and healthy control groups p<0.01; ** – the prob-
able difference between two groups of children with pyelonephritis p<0.01
In order to establish the possible role of undifferentiated dysplasia of connective tissue, as 
causes of more severe pyelonephritis in children and the propensity to chronize the process, as well 
as to predict frequent relapses of pyelonephritis in children, all children with pyelonephritis have 
been evaluated for the levels of oxyproline in plasma and urine as an indicator of increased collagen 
metabolism and a violation of fibrillogenesis. The obtained data were compared with the data of 
healthy children in the control group (Table 4).
In order to study the processes of collagen degradation in children of both groups of ob-
servation, the level of oxyproline in urine as a measure of collagen metabolism and violation of 
fibrillogenesis was determined by the method of qualitative reaction (by degree of opacity) for 
all children. The results of excretion of oxyproline with daily urine in children of both groups 
of surveillance with pyelonephritis compared with the data of healthy children are presented 
in Table 5.
Table 4
Indices of collagen collapse in children with pyelonephritis, (М±m)
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Indices
Groups of children:
І-CP, n=92 ІІ-AP, n=56 ІІІ-health-control, n=65
M±m q M±m q M±m q
Free oxyproline, μmol/l 47.14±0.03*.** 0.87*.** 17.65± 0.01* 0.12* 12.64±0.38 0.08*
Bound oxyproline, μmol/l 40.08±0.03*.** 0.78*.** 17.22±0.02* 0.16* 8.3±0.29 0.06*
Note:* – the probable difference between the data of children with pyelonephritis and healthy control groups p<0.01; ** – the prob-
able difference between two groups of children with pyelonephritis p<0.01
Table 5
The content of oxyproline in the urine of children with pyelonephritis
Indices:
Groups of children:
І-CP, n=92 ІІ-AP, n=56 ІІІ-health-control, n=65
М±m q М±m q М±m q
Oxyproline in urine (+),  
units of measurement 0.640.02± 0.97* 0.120.01± 0.10 0.060.01± 0.08
Note:* – the probable difference between the data of children with pyelonephritis and healthy control groups p<0.01; ** – the prob-
able difference between two groups of children with pyelonephritis p<0.01
5. Discussion
Comparison of the frequencies of ante- and postnatal non-specific risk factors for the forma-
tion of pathology showed that children with chronic pyelonephritis were significantly more likely 
to be on early artificial feeding in the first year of life (in the I group 52.17 % of children, in the 
comparison group – 23.21 %, in control – 0.14 %), were more likely to have acute respiratory dis-
eases (in the I group – 60.87 %, against 30.36 % of the children in the comparison group, in the 
control – 0.12 %), the children of both groups were prone to atopy (8.1 % of children in the It group 
against 8.93 % of the children in the comparison group, in control – 0.02 %). Mothers of children 
of the I group were significantly more likely to have anemia during pregnancy (almost 3 times: 
61.96 % vs. 21.43 %, 0.08 % control) and 2 times more likely to have clinical manifestations of 
gestosis in the first half of pregnancy ( table 1).
The obtained data allow us to conclude that the frequency of nonspecific ante- and postnatal 
risk factors for the formation of pathology plays an important role in the formation of nephrological 
diseases and affects the severity and frequency of relapses of pyelonephritis in the future.
At admission to children of the I group, complaints of frequent abdominal pain were noted 
in 52.17 % of cases, while in children of the ІІ group only 32.14 % of the subjects (in control – 
7.5 %). Complaints on frequent headaches were noted in 56.52 % of children in group І, whereas in 
children of the group ІІ only 25.0 % (in control – 4.2 %). Fatigue complaints were noted in 41.3 % 
of children in group І, whereas in children of group ІІ fatigue was noted only in 28.57 % of children 
(in control – 5.6 %). Dysuria in children of the I group was noted in 63.04 % of children, while in II 
group – only in 55.35 % of children (in control – 2.04 %). In addition, complaints of frequent nasal 
haemorrhage were noted in 4.34 % of children in group I, which was not observed in children of 
the group II (in control – 0.02 %).
Clinical manifestations of general non-specific intoxication were registered in most children 
of the I group: pallor of the skin was noted in 1.5–2 times more often than in children of the II 
group (52.0 % vs. 32.0 % of the children in the comparison group), periorbital cyanosis was noted 
2 times more frequently in patients of the I group (43.0 % vs. 23.0 % of the children in the compar-
ison group), signs of dysmetabolic nephropathy according to ultrasound data were also diagnosed 
2.5 times more often in children of the main group (57.0 % vs. 20.0 % of children in the comparison 
group), ultrasound signs of inflammatory renal disease met in 93.0 % of the both group. Reliable 
difference in performance of muffled heart tones, dental enamel hypoplasia in children of observa-
tion groups were not noted (Table 2).
The analysis of the frequency of phenotypic manifestations of UCTD in the examined chil-
dren indicates that in children of group I phenothylic signs of undifferentiated connective tissue 
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dysplasia, such as hypermobility of joints (52.0 % of children versus 5.4 % in the comparison 
group, in control – 3.07 %), asthenic body structure (59.0 % vs. 26.78 %, in control – 12.3 %), visual 
impairment (84.8 % vs. 32.14 %, control 7.69 %), deformation of the chest (42.4 % vs. 8.9 %, in con-
trol – 4.62 %), scoliosis posture (52.17 % vs. 10.7 %, in control – 4.62 %), arachnodactyly and pre-
disposition to bleeding noticed only in children of the I group (22.5 % and 4.34 % respectively, in 
the control – 0.0 %), which was not observed in children of the II group. The analysis of phenotypic 
manifestations of violations of fibrilogenesis points to the role of undifferentiated connective tissue 
dysplasia, as the causes of the more severe course of pyelonephritis in children and the propensity 
to chronize the process and predicts frequent relapses of pyelonephritis in children.
According to the literature in older children of the reference group, the level of free and 
bound oxyproline in the blood plasma is 12.2±0.49 μmol/l and 8.6±0.34 μmol/l, respectively. The 
higher the figure, the greater is collagen exchange [5].
In almost all of the examined children of both groups, the rates of increased collagen metab-
olism were significantly higher than healthy children (Table 4). However, in children of I group, the 
increased rates of free and bound oxyproline fractions in blood plasma were diagnosed in a larger 
number of children (78.0 % and 48.0 % respectively), with mean arithmetic data significantly dif-
fering from those in the children of the second group (12.0 % and 16.0 % respectively), indicating 
an increased collagen exchange in children with chronic and frequent relapses of pyelonephritis.
Determination of the level of oxyproline in the urine of children with pyelonephritis testifies 
to increased decay and excretion of collagen metabolism products in the child’s body in 97.0 % of 
the examined children of the I group, which significantly exceeds the level of excreted oxyproline 
in the urine in children of the ІІ group (10 %), which indicates a violation of the connective tissue 
catabolism in virtually all children with chronic pyelonephritis.
Consequently, after analyzing the results of the clinical and paraclinical examination of chil-
dren with different course of pyelonephritis, one can conclude that undifferentiated connective tissue 
dysplasia plays an important role in the process of chronic pyelonephritis in children, and children 
with UCTD manifestations have a more severe course of the disease with frequent relapses, so the 
presence of signs of UCTD is prognostically unsuccessful, which makes you think over the necessity 
of appointing nephroprotective and metabolic therapy in the first episodes of the onset of the disease 
in children in the presence of they have clinical and laboratory manifestations of UCTD.
6. Conclusions
1. The presence of nonspecific ante- and postnatal risk factors for the formation of pathology 
plays an important role in the formation of nephrological pathology in children.
2. In children with chronic pyelonephritis with frequent relapses, the frequency of almost 
all analyzed complaints was significantly and reliable higher than in children with acute pyelo-
nephritis without relapses: frequent headaches – 56.52 % vs. 25.0 % respectively), appetite loss – 
28.26 % vs. 19.64 %, frequent abdominal pain – 52.17 % versus 32.14 %, increased fatigue – 
41.30 % versus 28.57 %.
3. In children with chronic pyelonephritis and inclination to frequent relapse, phenotyp-
ic signs of undifferentiated connective dysplasia such as joint hypermobility (52.0 % of children 
versus 5.4 % in the comparison group), asthenic body structure of 59.0 % vs. 26.78 %), visual 
disturbance (84.8 % vs. 32.14 %), chest deformity (42.4 % vs. 8.9 %), scoliosis posture (52.17 % vs 
10.7 %), Arachnodactilus and predisposition to bleeding were noted only in children of I group 
(22.5 % and 4.34 % respectively).
4. In almost all examined children with chronic pyelonephritis, the values of free and bound 
fractions of oxyproline in blood plasma (47.14±0.03 μmol/l and 40.08±0.03 μmol/l respectively) 
were significantly increased, for the mean arithmetic data significantly differ from the data of 
children with acute pyelonephritis (17.65±0.01 μmol/l and 17.22±0.02 μmol/l), in which these oxy-
proline fractions were elevated only in 12.0 % and 16.0 % examined, respectively, indicating an 
enhanced collagen exchange in children with chronic pyelonephritis.
5. Determination of the level of oxyproline in urine in children with chronic pyelonephritis 
testifies to increased decay and excretion of collagen metabolism products in a child’s body in 
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97.0 % of the subjects, which significantly exceeds the level of excretion of oxyproline in urine in 
children with acute pyelonephritis, indicating the expressed disturbance of collagen catabolism in 
children prone to recurrence of pyelonephritis.
6. The presence of undifferentiated connective tissue dysplasia in the child plays an import-
ant role in the process of chronic pyelonephritis, and children with UCTD manifestations have a 
heavier course of disease with frequent relapses, therefore, the presence of signs of UCTD is prog-
nostically unsuccessful, which dictates the need for appointment of metabolic therapy in the first 
episodes of the disease in children, if they have clinical and laboratory manifestations of UCTD.
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Abstract
Patients who have contraindications to the prescription of GCs (glucocorticosteroids), or have developed serious side effects 
during treatment with GCs, as well as patients with resistance to GCs therapy, are prescribed immunosuppressants.
The aim of the research - to study the efficacy of leflunomide monotherapy in patients with pulmonary sarcoidosis with con-
traindications to prescription or serious side effects of glucocorticosteroids.
Fourteen patients with sarcoidosis of the respiratory system of stage II were examined – 12 women and 2 men aged 30 to 
 69 years. In 10 patients there were contraindications to the appointment of GCs (diabetes mellitus – 5, hypertension – 3, obesity – 1, 
exacerbation of gastric ulcer – 1), which caused the appointment of immunosuppressive therapy as a starting. In 4 cases, serious side 
effects of SCs were noted, requiring the drug to be abolished (osteoporosis – 3, steroid diabetes – 1). Leflunomide was administered 
at a dose of 20 mg per day, daily for 3 months. The evaluation of efficacy was carried out using computed tomography of the thoracic 
cavity organs, body plethysmography, spirometry and determination of the diffusivity of the lungs.
Monotherapy with leflunomide in patients with contraindications to prescription or serious side effects of GCs was successful 
in 7 out of 13 patients, in 2 patients there was a stabilization of the process, in 4 patients with leflunomide therapy progression of the 
disease was noted and in 1 case the treatment was discontinued due to serious side effects of preparation.
The results obtained make it possible to recommend the use of leflunomide as monotherapy in patients with pulmonary 
sarcoidosis with contraindications to the prescription and/or poor tolerability of GCs and methotrexate. It is necessary to continue 
studying the possibilities of combined use of leflunomide with other drugs of the first line.
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1. Introduction
The main drugs for the treatment of sarcoidosis are glucocorticosteroids, their effective-
ness has been proven in several randomized researches [1, 2]. Despite the fact that corticosteroids 
remain the first-line drugs for most patients, cytostatics have been recognized as alternative 
drugs for the treatment of sarcoidosis. Methotrexate is the most commonly used cytotoxic drug, 
